← Leaderboards
Heather Wynnvezina
University Of Minnesota Twin Cities
$17,930
Attributed
$17,930
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $8.3K · FY2005–08$10K$7.5K$5K$2.5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$17,930 · 4
By mechanism
M01$17,930 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Dorothy K Hatsukami$58,862,572
- Daniel A Vallera$6,910,381
- Courtney V. Fletcher$8,186,840
- Li-Na Wei$20,040,840
- Bernhard Josef Hering$29,197,217
Others in their field
Top investigators on “Acyclovir”
- Connie L Celum · University Of Washington$20,273,946
- Wafaa M. El-Sadr · Columbia University Health Sciences$20,205,932
- Davangere P Devanand · Columbia University Health Sciences$10,647,564
- Deepak Shukla · University Of Illinois At Chicago$8,847,409
- Thomas J. Smith · Control Delivery Systems, Inc.$7,339,085
- Betsy C. Herold · Children'S Hospital Med Ctr (Cincinnati)$6,908,134
Research focus
AcyclovirAdultCharacteristicsComputer Retrieval Of Information On Scientific Projects DatabaseDrug KineticsFundingGrantHerpesvirus 4, HumanInstitutionPharmacodynamicsPurposeResearch PersonnelResourcesResponseSourceUnited States National Institutes Of HealthValacyclovirViral Load ResultVirus
Grant awards (4)
PHARMACOKINETIC AND PHARMACODYNAMIC CHARACTERISTICS OF VALACYCLOVIR IN ADULTS WI$441
M01 · FY2008 · RR · contact PI
PHARMACOKINETIC AND PHARMACODYNAMIC CHARACTERISTICS OF VALACYCLOVIR IN ADULTS WI$2,618
M01 · FY2007 · RR · contact PI
POPULATION PHARMACOKINETICS OF GANCICLOVIR IN PEDIATRIC TRANSPLANT PATIENTS$6,600
M01 · FY2006 · RR · contact PI
POPULATION PHARMACOKINETICS OF GANCICLOVIR IN PEDIATRIC TRANSPLANT PATIENTS$8,271
M01 · FY2005 · RR